About MOVO-X
Built for ASEAN healthcare.
From the inside.
MOVO-X was built by a founder who spent years working with healthcare facilities across Southeast Asia — watching patients queue for 30+ minutes to complete a paper registration form, watching receptionists manually key in the same demographic fields for the tenth time that morning.
The problem no one had solved
The healthcare digitalisation gap in ASEAN is not a technology gap — it's an architecture gap. Every major hospital software vendor in the world built for the US or EU market. When they came to Southeast Asia, they localised the interface. They did not localise the architecture.
That meant no native support for MyKad or NRIC scanning. No integration with FPX, DuitNow, or PayNow. No understanding of how KPJ or IHH structure their hospital groups — 30 to 80 facilities under a single holding company, all sharing patient identity but keeping clinical data siloed by facility. And absolutely no compliance posture for PDPA 2010, PHFSA 1998, or Singapore's HBRA.
MOVO-X was founded on a single conviction: ASEAN's hospital groups deserved an enterprise operating platform built specifically for them. Not adapted. Not translated. Built from scratch, with the right compliance architecture, the right payment rails, the right language support, and the right tenancy model for how hospital groups actually operate in this region.
The first production deployment was at Klinik Muhibbah in Pasir Gudang, Malaysia — a real clinic, with real patients, where the founder watched the system process its first check-in in under 3 seconds. That clinic has now processed over 27,000 patients. KPJ Healthcare — Malaysia's largest private hospital group — is live on MOVO-X. Three countries. One platform.
What We Believe
Principles that aren't negotiable.
Privacy-first. Always.
Patient data stays in-country, full stop. Every MOVO-X deployment runs with jurisdiction-isolated infrastructure, AES-256 encryption at rest and in transit, and zero cross-border PHI transfer. We built on-premise AI specifically because cloud-based LLM triage was not acceptable to us — or to the hospitals we work with.
Country-native, not translated.
We don't take a US product and adapt it for Asia. We architect from scratch for each country — MyKad scanning in Malaysia, provincial health card validation in Canada, SingPass/NRIC in Singapore. Local payment rails. Local compliance. Local clinical standards. Purpose-built, not repurposed.
Clinical-grade or nothing.
Healthcare software that fails is not just a bad product — it's a patient safety risk. We build with HIPAA-equivalent standards, 7-year audit trails, structured clinical handoff formats (SOAP), and 99.9% uptime architecture. Our 62/62 end-to-end tests run on every deployment. No exceptions.
Enterprise-first from day one.
We never built a consumer app. MOVO-X was designed for hospital groups — organisations with 10 to 100+ facilities, complex procurement cycles, multi-department deployment needs, and zero tolerance for operational disruption. KPJ Healthcare as our first anchor customer reflects that choice.
Our Journey
From first commit to KPJ live.
Why multi-country from day one
Most healthcare software companies pick one market and go deep. We made a deliberate choice to build multi-country from the start — and it was the right decision.
The reason: ASEAN hospital groups are themselves multi-country. IHH Healthcare operates in Malaysia, Singapore, India, Turkey, and beyond. Raffles Medical has facilities in Singapore, China, Japan, and Cambodia. If we could only serve one country, we could never win an IHH-level enterprise deal.
Canada was a deliberate geographic hedge — a mature, regulated market with deep healthcare IT spending — that proves MOVO-X is not an emerging-markets-only platform. A hospital in Quebec and a hospital in Kuala Lumpur run on the same 4-tier tenancy architecture. The compliance layers differ. The infrastructure does not.
This architecture decision — one platform, multiple compliance layers — is now a core competitive moat. It took 18 months and hundreds of hours of regulatory research to build. No competitor has replicated it.
Building the next chapter.
We are raising our Series A to scale across IHH, Raffles Medical, and three new ASEAN markets. If you share our conviction on ASEAN healthcare, we want to talk.